Elisa Isopi
Chieti, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Editorial: Specialized proresolving mediators: Benefits within and beyond inflammation resolution in cardiometabolic, neurological and psychiatric disorders.
Journal: Frontiers in physiology
Published: February 28, 2023
Resolvin D1 reduces cancer growth stimulating a protective neutrophil-dependent recruitment of anti-tumor monocytes.
Journal: Journal of experimental & clinical cancer research : CR
Published: January 12, 2021
Roles of Specialized Pro-Resolving Lipid Mediators in Autophagy and Inflammation.
Journal: International journal of molecular sciences
Published: August 20, 2020
Resolvin D1 Reduces Lung Infection and Inflammation Activating Resolution in Cystic Fibrosis.
Journal: Frontiers in immunology
Published: December 13, 2019
Roles, Actions, and Therapeutic Potential of Specialized Pro-resolving Lipid Mediators for the Treatment of Inflammation in Cystic Fibrosis.
Journal: Frontiers in pharmacology
Published: December 13, 2018
Effects of peptidyl-prolyl isomerase 1 depletion in animal models of prion diseases.
Journal: Prion
Published: April 21, 2018
α-Synuclein Amyloids Hijack Prion Protein to Gain Cell Entry, Facilitate Cell-to-Cell Spreading and Block Prion Replication.
Journal: Scientific reports
Published: March 07, 2017
Resolvin D1 enhances the resolution of lung inflammation caused by long-term Pseudomonas aeruginosa infection.
Journal: Mucosal immunology
Published: September 12, 2016
Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology.
Journal: Neurobiology of disease
Published: September 20, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026